$SRNE News Article - Sorrento Announces FDA Author
Post# of 114
(Total Views: 263)
Posted On: 05/17/2022 2:50:53 PM
$SRNE News Article - Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee(TM)) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial) https://marketwirenews.com/news-releases/sorr...19345.html
(0)
(0)Sorrento Therapeutics Inc. (SRNE) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼